Table 3.

IMR Pilot Study Assessment Measures

Baseline (N = 24)		Posttreatment (N = 24)		Follow-up (N = 17)
M	SD	M	SD	M	SD	F (df)	P	d
Illness management
BSI GSIa	1.03	0.17	0.92	0.15	0.77	0.14	4.37 (2, 22)	.03	.50
Coping—total symptomsb	6.05	1.07	4.62	0.95	5.87	1.18	2.28 (2, 14)	.14	.38
Coping effectivec	3.05	0.28	3.55	0.27	3.25	0.21	3.79 (2, 22)	.04	.84
Client IMR—shortened/sumc,d	36.97	2.29	45.82	2.18	42.08	2.62	10.82 (2, 16)	.00	.83
Knowledge of illnessd,e	91.52	1.38	95.32	0.86	94.66	1.34	6.63 (2, 23)	.01	.63
Social support	45.82	1.96	47.65	1.64	46.90	1.88	0.44 (2, 20)	.65	.18
Recovery
Recovery meand,e	3.81	0.10	3.98	0.10	4.04	0.11	4.76 (2, 41)	.01	.64
RAS—hoped,e	32.75	1.14	34.27	1.14	34.96	1.19	3.66 (2, 40)	.04	.55
RAS—willingness ask help	12.11	0.32	12.91	0.32	12.73	0.36	2.71 (2, 40)	.08	.30
RAS—goal orientedd,e	18.75	0.84	20.17	0.84	20.94	0.91	3.28 (2, 39)	.05	.48
RAS—rely on others	16.90	0.41	16.53	0.41	17.03	0.44	1.24 (2, 41)	.30	.02
RAS—not dominated symptomd,e	9.95	0.54	11.24	0.54	11.48	0.60	3.48 (2, 41)	.04	.60
GAFd,e	53.71	2.43	61.45	3.05	59.99	3.43	10.91 (2, 18)	.00	.80

Note: IMR, Illness Management and Recovery; BSI, Brief Symptom Inventory; GSI, global severity index, GAF, Global Assessment of Functioning.

^aBaseline > follow-up (P < .05).

^bN = 16.

^cN = 15.

^dBaseline < posttest (P < .05).

^eBaseline < follow-up (P < .05).